These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38333208)

  • 1. Etanercept treatment for pediatric toxic epidermal necrolysis induced by deflazacort: a case report and literature review.
    Jeong MS; Choi YY; Ahn YH; Lee K; Park JS; Suh DI
    Front Immunol; 2024; 15():1342898. PubMed ID: 38333208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome.
    Jacobsen A; Olabi B; Langley A; Beecker J; Mutter E; Shelley A; Worley B; Ramsay T; Saavedra A; Parker R; Stewart F; Pardo Pardo J
    Cochrane Database Syst Rev; 2022 Mar; 3(3):CD013130. PubMed ID: 35274741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Combination Therapy With Etanercept and Systemic Corticosteroids for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Multicenter Observational Study.
    Zhang J; Lu CW; Chen CB; Wang CW; Chen WT; Cheng B; Ji C; Chung WH
    J Allergy Clin Immunol Pract; 2022 May; 10(5):1295-1304.e6. PubMed ID: 35131514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Halted by Etanercept.
    Gavigan GM; Kanigsberg ND; Ramien ML
    J Cutan Med Surg; 2018; 22(5):514-515. PubMed ID: 29421925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Case Report and Literature Review.
    Meledathu S; Gordon M; Thornton M; Ashinoff R
    J Drugs Dermatol; 2023 Nov; 22(11):e24-e28. PubMed ID: 37943271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levetiracetam-induced pediatric toxic epidermal necrolysis successfully treated with etanercept.
    Estébanez A; Sáez-Martín LC; Muñoz JI; Silva E; Monrabal A; Monteagudo C; Ramón MD
    Pediatr Dermatol; 2020 Jul; 37(4):701-705. PubMed ID: 32319121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective review of drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis cases at a pediatric tertiary care institution.
    Sibbald C; Putterman E; Micheletti R; Treat J; Castelo-Soccio L
    Pediatr Dermatol; 2020 May; 37(3):461-466. PubMed ID: 32058621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of etanercept for treatment of toxic epidermal necrolysis when toxic shock syndrome is in the differential.
    So N; Leavitt E; Aleshin M; Worswick S
    Dermatol Ther; 2018 Sep; 31(5):e12684. PubMed ID: 30175438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions.
    Wang CW; Yang LY; Chen CB; Ho HC; Hung SI; Yang CH; Chang CJ; Su SC; Hui RC; Chin SW; Huang LF; Lin YY; Chang WY; Fan WL; Yang CY; Ho JC; Chang YC; Lu CW; Chung WH;
    J Clin Invest; 2018 Mar; 128(3):985-996. PubMed ID: 29400697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric SJS/TEN Subdued by a Combination of Dexamethasone, Cyclosporine, and Etanercept.
    Coulombe J; Belzile E; Duhamel A; Rault P; Buteau C; DeBruycker JJ; Bussières JF
    J Cutan Med Surg; 2019; 23(5):547-550. PubMed ID: 31478770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etanercept treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Tian CC; Ai XC; Ma JC; Hu FQ; Liu XT; Luo YJ; Tan GZ; Zhang JM; Li XQ; Guo Q; Zeng FQ; Shi ZR; Wang L
    Ann Allergy Asthma Immunol; 2022 Sep; 129(3):360-365.e1. PubMed ID: 35598882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxic Epidermal Necrolysis: A Review of Past and Present Therapeutic Approaches.
    Singh N; Phillips M
    Skin Therapy Lett; 2022 Sep; 27(5):7-13. PubMed ID: 36469487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Etanercept in the Treatment of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Dreyer SD; Torres J; Stoddard M; Leavitt E; Sutton A; Aleshin M; Crew A; Worswick S
    Cutis; 2021 Jun; 107(6):E22-E28. PubMed ID: 34314327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linear immunoglobulin A dermatosis mimicking toxic epidermal necrolysis: a case report of etanercept treatment.
    Prieto-Barrios M; Velasco-Tamariz V; Tous-Romero F; Burillo-Martinez S; Zarco-Olivo C; Rodriguez-Peralto JL; Ortiz-Romero PL
    Br J Dermatol; 2018 Mar; 178(3):786-789. PubMed ID: 28222222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologic TNF-alpha inhibitors in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis: a systemic review.
    Zhang S; Tang S; Li S; Pan Y; Ding Y
    J Dermatolog Treat; 2020 Feb; 31(1):66-73. PubMed ID: 30702955
    [No Abstract]   [Full Text] [Related]  

  • 16. Combination therapy: Etanercept and intravenous immunoglobulin for the acute treatment of Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Pham CH; Gillenwater TJ; Nagengast E; McCullough MC; Peng DH; Garner WL
    Burns; 2019 Nov; 45(7):1634-1638. PubMed ID: 31466921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid remission of Stevens-Johnson syndrome by combination therapy using etanercept and intravenous immunoglobulin and a review of the literature.
    Wang R; Zhong S; Tu P; Li R; Wang M
    Dermatol Ther; 2019 Jul; 32(4):e12832. PubMed ID: 30659711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Bayesian Network Meta-Analysis of the Effect of Targeted Therapies on the Total Length of Hospital Stay in Children with Drug-Induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Syndrome.
    Ozerturk S; Derici Yildirim D; Arikoglu T; Kuyucu S; Kont Ozhan A
    Pediatr Allergy Immunol Pulmonol; 2024 Mar; 37(1):22-32. PubMed ID: 38484271
    [No Abstract]   [Full Text] [Related]  

  • 19. A new case series on etanercept treatment for toxic epidermal necrolysis.
    Paradisi A; Abeni D; Didona D; Ricci F; Canzona F; Didona B
    Eur J Dermatol; 2020 Oct; 30(5):561-568. PubMed ID: 33021477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Odynophagia as the first manifestation of toxic epidermal necrolysis.
    Ortega Beltrá N; Guallart Domenech F; Martínez Ruiz de Apodaca P; Pons Rocher F
    BMJ Case Rep; 2022 Nov; 15(11):. PubMed ID: 36423938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.